Brief report: acamprosate in fragile X syndrome (Q43137846)

14 November 2017

Brief report: acamprosate in fragile X syndrome (English)

1 reference

14 November 2017

1 reference

Christopher J McDougle

series ordinal

3

object named as

Christopher J McDougle

1 reference

14 November 2017

Craig A Erickson

1

1 reference

PubMed ID

20213249

14 November 2017

Jennifer E Mullett

series ordinal

2

1 reference

PubMed ID

20213249

14 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Journal of Autism and Developmental Disorders

14 November 2017

1 reference

14 November 2017

40

1 reference

14 November 2017

1412-1416

1 reference

14 November 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s10803-010-0988-9

14 November 2017

0 references

cites work

Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-010-0988-9

Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-010-0988-9

Acamprosate: recent findings and future research directions

21 January 2018

1 reference

12 December 2020

Effects of Acamprosate on Neuronal Receptors and Ion Channels Expressed inXenopusOocytes

1 reference

12 December 2020

Synaptic regulation of protein synthesis and the fragile X protein

1 reference

12 December 2020

The fragile X prevalence paradox

1 reference

12 December 2020

Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.

1 reference

12 December 2020

The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation

1 reference

12 December 2020

Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome

1 reference

12 December 2020

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.

1 reference

12 December 2020

Correction of fragile X syndrome in mice.

1 reference

12 December 2020

Absence of expression of the FMR-1 gene in fragile X syndrome

1 reference

12 December 2020

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

1 reference

12 December 2020

Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action

1 reference

12 December 2020

Open-label memantine in fragile X syndrome.

1 reference

12 December 2020

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

12 December 2020

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

1 reference

12 December 2020

Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.

1 reference

12 December 2020

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome

1 reference

12 December 2020

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse

1 reference

12 December 2020

Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency

1 reference

12 December 2020

Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.

1 reference

12 December 2020

Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain

1 reference

12 December 2020

Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice

1 reference

12 December 2020

The mGluR theory of fragile X mental retardation

1 reference

12 December 2020

Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome

1 reference

12 December 2020

10.1007/S10803-010-0988-9

Identifiers

DOI

1 reference

14 November 2017

1 reference

PubMed ID

20213249